NL-OMON56142已完成不适用
Combining contrast enhanced mammography and radio-active free magnetic seed localization of non-palpable breast tumors: A feasibility study - CEMMAG
Zuyderland Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Women scheduled for breast conservative therapy for a non-palpable breast
- •lesion requiring image-guided localization using a magnetic seed.
排除标准
- •Unable to provide written informed consent. Age <18 years. Pregnancy.
研究者
相似试验
已完成
不适用
Clinical study of contrast-enhanced mammography on pre-operative diagnosis of breast cancerBreast cancerJPRN-UMIN000026800Dokkyo Medical University Koshigaya Hospital50
已完成
不适用
Is contrast enhanced spectral mammography (CESM) useful in the investigation of possible abnormalities found on screening mammograms in women with dense breast tissue and does it add useful and important information over and above current standard imaging tests?Cancer - BreastBreast CancerACTRN12616000533493Royal Perth Hospital69
招募中
不适用
Efficacy of contrast enhanced spectral mammography (CESM)JPRN-UMIN000005680Showa University60
进行中（未招募）
1 期
Evaluation of the use of contrast agent in mammography to improve the specificity of breast cancer diagnosisPatients with breast lesions undergoing further examinationMedDRA version: 20.0Level: PTClassification code 10061021Term: Breast disorderSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2019-000326-22-ITISTITUTO EUROPEO DI ONCOLOGIA170
进行中（未招募）
1 期
Role of contrast enhanced mammography with Iomeprol 400 mgI/ml (Iomeron, Bracco), in the identification of breast cancer: I3-MaC StudyMedDRA version: 21.1Level: PTClassification code: 10057654Term: Breast cancer female Class: 100000004864Breast cancerCTIS2024-513251-32-00Azienda Ospedaliero-Universitaria Policlinico Umberto I173